PMID- 28590303 OWN - NLM STAT- MEDLINE DCOM- 20180416 LR - 20200317 IS - 1473-5849 (Electronic) IS - 0955-8810 (Linking) VI - 28 IP - 6 DP - 2017 Sep TI - The immunomodulatory tellurium compound ammonium trichloro (dioxoethylene-O,O') tellurate reduces anxiety-like behavior and corticosterone levels of submissive mice. PG - 458-465 LID - 10.1097/FBP.0000000000000319 [doi] AB - Ammonium trichloro (dioxoethylene-O,O') tellurate (AS101) is a synthetic organotellurium compound with potent immunomodulatory and neuroprotective properties shown to inhibit the function of integrin alphavbeta3, a presynaptic cell-surface-adhesion receptor. As partial deletion of alphavbeta3 downregulated reuptake of serotonin by the serotonin transporter, we hypothesized that AS101 may influence pathways regulating anxiety. AS101 was tested in the modulation of anxiety-like behavior using the selectively bred Submissive (Sub) mouse strain that develop anxiety-like behavior in response to an i.p. injection. Mice were treated daily with AS101 (i.p., 125 or 200 mug/kg) or vehicle for 3 weeks, after which their anxiety-like behavior was measured in the elevated plus maze. Animals were then culled for the measurement of serum corticosterone levels by ELISA and hippocampal expression of brain-derived neurotrophic factor (BDNF) by RT-PCR. Chronic administration of AS101 significantly reduced anxiety-like behavior of Sub mice in the elevated plus maze, according to both time spent and entries to open arms, relative to vehicle-treated controls. AS101 also markedly reduced serum corticosterone levels of the treated mice and increased their hippocampal BDNF expression. Anxiolytic-like effects of AS101 may be attributed to the modulation of the regulatory influence integrin of alphavbeta3 upon the serotonin transporter, suggesting a multifaceted mechanism by which AS101 buffers the hypothalamic-pituitary-adrenal axis response to injection stress, enabling recovery of hippocampal BDNF expression and anxiety-like behavior in Sub mice. Further studies should advance the potential of AS101 in the context of anxiety-related disorders. FAU - Gross, Moshe AU - Gross M AD - aDepartment of Molecular Biology, Ariel University, Ariel bThe Safdie AIDS and Immunology Research Center, C.A.I.R. Institute, The Mina and Everard Goodman Faculty of Life Sciences cInterdisciplinary Department, Faculty of Social Sciences, Bar-Ilan University, Ramat-Gan, Israel. FAU - Stanciu, Emanuel AU - Stanciu E FAU - Kenigsbuch-Sredni, Dvora AU - Kenigsbuch-Sredni D FAU - Sredni, Benjamin AU - Sredni B FAU - Pinhasov, Albert AU - Pinhasov A LA - eng PT - Journal Article PL - England TA - Behav Pharmacol JT - Behavioural pharmacology JID - 9013016 RN - 0 (Ammonium Compounds) RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Ethylenes) RN - 0 (Integrin alphaVbeta3) RN - 0 (Neuroprotective Agents) RN - 708681952A (ammonium trichloro(dioxoethylene-O,O'-)tellurate) RN - NQA0O090ZJ (Tellurium) RN - W980KJ009P (Corticosterone) SB - IM MH - Ammonium Compounds MH - Animals MH - Anxiety/*drug therapy/metabolism MH - Brain-Derived Neurotrophic Factor/metabolism MH - Corticosterone/analysis/blood MH - Disease Models, Animal MH - Ethylenes/metabolism/*pharmacology MH - Hypothalamo-Hypophyseal System/metabolism MH - Immunomodulation MH - Integrin alphaVbeta3/metabolism MH - Mice MH - Neuroprotective Agents MH - Pituitary-Adrenal System/metabolism MH - Tellurium EDAT- 2017/06/08 06:00 MHDA- 2018/04/17 06:00 CRDT- 2017/06/08 06:00 PHST- 2017/06/08 06:00 [pubmed] PHST- 2018/04/17 06:00 [medline] PHST- 2017/06/08 06:00 [entrez] AID - 10.1097/FBP.0000000000000319 [doi] PST - ppublish SO - Behav Pharmacol. 2017 Sep;28(6):458-465. doi: 10.1097/FBP.0000000000000319.